Johns Hopkins Medicine and Walgreens announced today they have entered into an agreement designed to develop protocols to improve outcomes of chronic disease patients and promote collaboration on population-based research, according to a release.
JHM and Walgreens will partner to explore new models for improving patient care, including a new educational and training program for Walgreens' 70,000 healthcare service providers.
According to the release, the agreement provides JHM with the opportunity to develop population-based research ideas with a partner that possesses advanced data systems and a large patient base. All patient information used for studies will be anonymous.
"Improving the care of people with chronic conditions, like asthma, diabetes, obesity, high blood pressure and heart disease, is a central goal of health professionals, health systems and U.S. policy makers," said Fred Brancati, MD, professor of medicine and director of the Division of General Internal Medicine at Johns Hopkins University School of Medicine. "It makes sense medically, and under health care reform, it makes sense financially, too. It's a part of the Hopkins mission that Walgreens can help us advance. Combining our clinical expertise and research know-how with their nationwide resources — including pharmacies, clinics, worksite health centers, information systems and 70,000 health care service providers — will generate new approaches to improve population health."
The agreement specifically sets up opportunities for research programs, clinical protocol development and review, professional training and clinical program development and health plan services, according to the report.
Related Articles on Johns Hopkins:
Study: Hospital Claims of Superior Robotic Surgery Not Always Backed By Evidence
Studies Find Dramatic Uptick in Prostate Biopsy Infections
Healthcare Providers Affected by Adverse Events Request Emotional Support, Peer Support
JHM and Walgreens will partner to explore new models for improving patient care, including a new educational and training program for Walgreens' 70,000 healthcare service providers.
According to the release, the agreement provides JHM with the opportunity to develop population-based research ideas with a partner that possesses advanced data systems and a large patient base. All patient information used for studies will be anonymous.
"Improving the care of people with chronic conditions, like asthma, diabetes, obesity, high blood pressure and heart disease, is a central goal of health professionals, health systems and U.S. policy makers," said Fred Brancati, MD, professor of medicine and director of the Division of General Internal Medicine at Johns Hopkins University School of Medicine. "It makes sense medically, and under health care reform, it makes sense financially, too. It's a part of the Hopkins mission that Walgreens can help us advance. Combining our clinical expertise and research know-how with their nationwide resources — including pharmacies, clinics, worksite health centers, information systems and 70,000 health care service providers — will generate new approaches to improve population health."
The agreement specifically sets up opportunities for research programs, clinical protocol development and review, professional training and clinical program development and health plan services, according to the report.
Related Articles on Johns Hopkins:
Study: Hospital Claims of Superior Robotic Surgery Not Always Backed By Evidence
Studies Find Dramatic Uptick in Prostate Biopsy Infections
Healthcare Providers Affected by Adverse Events Request Emotional Support, Peer Support